This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Osiris Therapeutics Inc (OSIR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 2.42M 1.85M 1.66M 1.44M
Receivables 22.72M 3.06M 728.00K 1.93M
Inventories 1.93M 1.28M 767.00K 510.00K
Other Current Assets 91.00K 0.00 0.00 0.00
Total Current Assets 84.11M 39.04M 51.42M 73.95M
Property, Plant & Equipment, Gross 6.05M 5.56M 5.23M 5.15M
Accumulated Depreciation & Depletion 4.15M 3.45M 2.77M 2.02M
Property, Plant & Equipment, Net 1.90M 2.11M 2.46M 3.13M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 243.00K 317.00K 392.00K 705.00K
Total Non-Current Assets 7.99M 2.43M 2.86M 3.83M
Liabilities & Shareholder Equity
Total Assets 92.10M 41.46M 54.27M 77.78M
Accounts Payable 4.84M 5.00M 4.69M 5.57M
Short Term Debt 45.00K 44.00K 0.00 0.00
Other Current Liabilities 57.00K 0.00 0.00 0.00
Total Current Liabilities 10.79M 5.04M 8.02M 46.53M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 355.00K 369.00K 430.00K 3.80M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 355.00K 531.00K 430.00K 3.80M
Total Liabilities 11.15M 5.57M 8.46M 50.33M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 80.95M 35.89M 45.82M 27.46M
Common Par 34.00K 33.00K 33.00K 33.00K
Additional Paid In Capital 282.70M 279.27M 278.09M 274.65M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -201.75M -243.39M -232.33M -247.22M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -33.00K -20.00K 20.00K -3.00K
Total Capitalization 80.95M 35.89M 45.82M 27.46M
Total Equity 80.95M 35.89M 45.82M 27.46M
Total Liabilities & Stock Equity 92.10M 41.46M 54.27M 77.78M
Total Common Shares Outstanding 34.12M 32.88M 32.83M 32.79M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 33.31M 32.86M 32.82M 32.78M
Diluted Weighted Shares Outstanding 33.31M 32.86M 33.12M 33.10M
Number of Employees 70 59 54 56
Number of Part-Time Employees 5 5 3 3
OSIR News

OSIR Osiris Therapeutics Inc

Analysts Ratings for OSIR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET OSIR ANALYST REPORT

Brokerage Partners

OSIR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs